44 min listen
Treatment of Acinetobacter spp. Infections (AAC ed.)
Treatment of Acinetobacter spp. Infections (AAC ed.)
ratings:
Length:
44 minutes
Released:
Dec 11, 2021
Format:
Podcast episode
Description
Infections caused by carbapenem-resistant Acinetobacter spp. are considered an urgent public health problem. Antibiotic options are scarce but new drugs may be available in the near future. We discuss this important topic with experts in the field. Topics discussed: Acinetobacter as an opportunistic pathogen Therapeutic approaches for Acinetobacter infections The future approach for this MDR organisms. Guests: Dr. Yohei Doi, Professor and Director, Center for Innovative Antimicrobial Therapy, University of Pittsburgh Medical Center, Pittsburgh, PA Dr. Joseph Patrick Hornak. Fellow, Infectious Diseases, University of Texas Medical Branch, Galveston, TX
Released:
Dec 11, 2021
Format:
Podcast episode
Titles in the series (81)
New Vancomycin Guidelines (AAC ed.): Discussing new guidelines on the use of vancomycin for severe Staphylocccus aureus infections. The August issue of AAC includes interesting papers about mechanism of resistance to metronidazole in C. difficile, a variant of KPC resistant to... by Editors in Conversation